Sitagliptin Glenmark 50 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sitagliptin glenmark 50 mg

glenmark pharmaceuticals s.r.o., Česká republika - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Sitagliptin Glenmark 25 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sitagliptin glenmark 25 mg

glenmark pharmaceuticals s.r.o., Česká republika - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Dasatinib Accord Európska únia - slovenčina - EMA (European Medicines Agency)

dasatinib accord

accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastické činidlá - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.

Dasatinib Accordpharma Európska únia - slovenčina - EMA (European Medicines Agency)

dasatinib accordpharma

accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastické činidlá - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase.  chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib.  ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib.  newly diagnosed ph+ all in combination with chemotherapy.

Lonamo 100 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

lonamo 100 mg

egis pharmaceuticals plc, maďarsko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Lonamo 50 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

lonamo 50 mg

egis pharmaceuticals plc, maďarsko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Mapoli 25 mg/ml perorálny roztok Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

mapoli 25 mg/ml perorálny roztok

glenmark pharmaceuticals s.r.o., Česká republika - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Sitagliptin Grindeks 100 mg filmom obalené tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sitagliptin grindeks 100 mg filmom obalené tablety

as grindeks, lotyšsko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Sitagliptin Grindeks 25 mg filmom obalené tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sitagliptin grindeks 25 mg filmom obalené tablety

as grindeks, lotyšsko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Sitagliptin Grindeks 50 mg filmom obalené tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sitagliptin grindeks 50 mg filmom obalené tablety

as grindeks, lotyšsko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)